ArticleDermatology practical & conceptual2023
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire.
Elisa Camela et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.